MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HUBS

Go back to MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D
Mannkind Corporation (NASDAQ: MNKD) Delayed: 4.06 +0.10 (2.53%)
Previous Close $3.96    52 Week High $2.51 
Open $3.92    52 Week Low $0.41 
Day High $4.10    P/E N/A 
Day Low $3.92    EPS $-0.64 
Volume 2,807,582       

Mannkind Corporation (NASDAQ: MNKD) Delayed: 4.06 +0.10 (2.53%)
Previous Close $3.96    52 Week High $2.51 
Open $3.92    52 Week Low $0.41 
Day High $4.10    P/E N/A 
Day Low $3.92    EPS $-0.64 
Volume 2,807,582